 intens combin chemotherapi autolog bone marrow transplant reappear philadelphia chromosome-neg cell chronic myelogen leukemia fifteen patient philadelphia chromosom Ph chronic myelogen leukemia cml inelig allogen bone marrow transplant bmt alpha-interferon therapi studi patient first late chronic phase second chronic phase acceler phase blastic phase autolog bone marrow cell median cells/kg median month diagnosi patient cyclophosphamid day carmustin bcnu day cbv reinfus autolog bone marrow hematopoiet recoveri rapid toxic mild patient patient cytomegaloviru pneumon eight patient Ph suppress ph-posit metaphas autolog bmt major cytogenet respons Ph suppress ph-posit metaphas patient cytogenet respons patient ph-posit marrow patient ph-mosaic marrow mixtur diploid ph-posit cell result autolog bmt chronic phase advanc phase major cytogenet respons month wherea cytogenet respons short time month patient chronic phase previou resist alpha-interferon therapi sensit alpha-interferon therapi autolog bmt author intens chemotherapi autolog bmt cytogenet remiss patient ph-posit cml diseas sensit alpha-interferon therapi patient use treatment chronic phase stem cell time previou cytogenet remiss